Diagnosis and management of upper extremity deep-vein thrombosis in adults

Thrombosis and Haemostasis

Volumn 108, Issue 6, 2012, Pages 1097-1108

  Grant, Jonathan D ^a   Stevens, Scott M ^b,c   Woller, Scott C ^b,c   Lee, Edward W ^d   Kee, Stephen T ^d   Liu, David M ^e   Lohan, Derek G ^f   Gregory Elliott, C ^b,c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b INTERMOUNTAIN MEDICAL CENTER   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^f UNIVERSITY HOSPITAL GALWAY   (Ireland)

Author keywords

Deep vein thrombosis; Diagnosis management; Magnetic resonance; Risk factors; Venous thrombosis

Indexed keywords

CONTRAST MEDIUM; D DIMER; FONDAPARINUX; GADOLINIUM; HEPARIN; WARFARIN;

ANGIOPLASTY; B SCAN; BLEEDING; BLOOD CLOT LYSIS; CENTRAL VENOUS CATHETER; CLINICAL FEATURE; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED TOMOGRAPHY; ENDOVASCULAR SURGERY; HUMAN; LOW DRUG DOSE; LUNG EMBOLISM; MECHANICAL THROMBECTOMY; META ANALYSIS (TOPIC); NEOPLASM; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS THROMBECTOMY; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PHLEBOGRAPHY; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SUBCLAVIAN VEIN CATHETER; SYSTEMATIC REVIEW (TOPIC); THROMBOPHILIA; UPPER EXTREMITY DEEP VEIN THROMBOSIS; VASCULAR STENT;

ADULT; AGED; ALGORITHMS; ANGIOPLASTY; ANTICOAGULANTS; CATHETERIZATION, CENTRAL VENOUS; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; PHLEBOGRAPHY; PROGNOSIS; RISK FACTORS; RISK REDUCTION BEHAVIOR; STENTS; THROMBECTOMY; THROMBOLYTIC THERAPY; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, COLOR; UPPER EXTREMITY DEEP VEIN THROMBOSIS;

EID: 84870867702     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH12-05-0352     Document Type: Review

References (99)

1. Kearon C, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133 (6 Suppl): 454S-545S.
2. Kucher N. Clinical practice. Deep-vein thrombosis of the upper extremities. N Engl J Med 2011; 364: 861-869.
3. Linnemann B, et al. Hereditary and acquired thrombophilia in patients with upper extremity deep-vein thrombosis. Results from the MAISTHRO registry. Thromb Haemost 2008; 100: 440-446.
4. Joffe H V, Goldhaber SZ. Upper-extremity deep vein thrombosis. Circulation 2002; 106: 1874-1880.
5. Hingorani A, et al. Upper extremity deep venous thrombosis and its impact on morbidity and mortality rates in a hospital-based population. J Vasc Surg 1997; 26: 853-860.
6. Owens CA, et al. Pulmonary embolism from upper extremity deep vein thrombosis and the role of superior vena cava filters: a review of the literature. J Vasc Inter v Radiol 2010; 21: 779-787.
7. Spencer FA, et al. Upper extremity deep vein thrombosis: a community-based perspective. Am J Med 2007; 120: 678-684.
8. Joffe H V, et al. Upper-extremity deep vein thrombosis: a prospective registry of 592 patients. Circulation 2004; 110: 1605-1611.
9. Kuter DJ. Thrombotic complications of central venous catheters in cancer patients. Oncologist 2004; 9: 207-216.
10. Luciani A, et al. Catheter-related upper extremity deep venous thrombosis in cancer patients: a prospective study based on Doppler US. Radiology 2001; 220: 655-660.
11. Martin C, et al. Upper-extremity deep vein thrombosis after central venous cathe-terization via the axillary vein. Crit Care Med 1999; 27: 2626-2629.
12. De Cicco M, et al. Central venous thrombosis: an early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study. Thromb Res 1997; 86: 101-113.
13. Bonfils P, et al. Prospective study of thromboses of the subclavian vein after setting implantable venous access systems in cervico-facial cancerology. Ann Oto-laryn-gol Chir Cervicofac 1996; 113: 425-429.
14. Bern MM, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 1990; 112: 423-428.
15. Mismetti P, et al. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial. Haematologica 2003; 88: 67-73.
16. Couban S, et al. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol 2005; 23: 4063-4069.
17. Verso M, et al. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol 2005; 23: 4057-4062.
18. Karthaus M, et al. Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann Oncol 2006; 17: 289-296.
19. Niers TM, et al. Prevention of catheter-related venous thrombosis with nadropa-rin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study. J Thromb Haemost 2007; 5: 1878-1882.
20. Cortelezzi A, et al. Incidence of thrombotic complications in patients with hae-matological malignancies with central venous catheters: a prospective multi-centre study. Br J Haematol 2005; 129: 811-817.
21. Lee AY, et al. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 2006; 24: 1404-1408.
22. Young AM, et al. Warfari n thromboprophylaxis i n cancer patients with centr al venous catheters (WARP): an open-label randomised trial. Lancet 2009; 373: 567-574.
23. Evans RS, et al. Risk of symptomatic DVT associated with peripherally inserted central catheters. Chest 2010; 138: 803-810.
24. van Rooden CJ, et al. Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study. J Clin Oncol 2005; 23: 2655-2660.
25. Saber W, et al. Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost 2011; 9: 312-319.
26. Korkeila P, et al. Progression of venous pathology after pacemaker and cardio-verter-defibrillator implantation: A prospective serial venographic study. Ann Med 2008; 31: 1-8.
27. Isma N, et al. Upper extremity deep venous thrombosis in the population-based Malmo thrombophilia study (MATS). Epidemiology, risk factors, recurrence risk, and mortality. Thromb Res 2010; 125: e335-338.
28. Anderson AJ, et al. Thrombosis: the major Hickman catheter complication in patients with solid tumor. Chest 1989; 95: 71-75.
29. Girolami A, et al. Venous thromboses of upper limbs are more frequently associated with occult cancer as compared with those of lower limbs. Blood Coagul Fi-brinolysis 1999; 10: 455-457.
30. Ellis MH, et al. Risk factors and management of patients with upper limb deep vein thrombosis. Chest 2000; 117: 43-46.
31. Kearon C, et al. Antithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e419S-e494S.
32. Chan WS, Ginsberg JS. A review of upper extremity deep vein thrombosis in pregnancy: unmasking the 'ART' behind the clot. J Thromb Haemost 2006; 4: 1673-1677.
33. Martinelli I, et al. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities. Circulation 2004; 110: 566-570.
34. Hingorani A, et al. Risk factors for mortality in patients with upper extremity and internal jugular deep venous thrombosis. J Vasc Surg 2005; 41: 476-478.
35. Prandoni P, et al. The long term clinical course of acute deep vein thrombosis of the arm: prospective cohort study. Br Med J 2004; 329: 484-485.
36. Horattas MC, et al. Changing concepts of deep venous thrombosis of the upper extremity--report of a series and review of the literature. Surgery 1988; 104: 561-567.
37. Kooij JD, et al. Pulmonary embolism in deep venous thrombosis of the upper extremity: more often in catheter-related thrombosis. Netherl J Med 1997; 50: 238-242.
38. Kerr TM, et al. Upper extremity venous thrombosis diagnosed by duplex scanning. Am J Surg 1990; 160: 202-206.
39. Munoz FJ, et al. Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry. Chest 2008; 133: 143-148.
40. Lechner D, et al. Comparison between idiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence. J Thromb Hae-most 2008; 6: 1269-1274.
41. Prandoni P, et al. Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications. Arch Intern Med 1997; 157: 57-62.
42. Elman EE, Kahn SR. The post-thrombotic syndrome after upper extremity deep venous thrombosis in adults: a systematic review. Thromb Res 2006; 117: 609-614.
43. Kahn SR, et al. Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e195S-e226S.
44. Wagman LD, et al. Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2008; 6: 716-753.
45. Evans RS, et al. Reduction of Peripherally Inserted Central Catheter Associated Deep Venous Thrombosis. Chest 2012; epub ahead of print.
46. Krafte-Jacobs B, et al. Catheter-related thrombosis in critically ill children: comparison of catheters with and without heparin bonding. J Ped 1995; 126: 50-54.
47. Pierce CM, et al. Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Inten Care Med 2000; 26: 967-972.
48. Anton N, et al. Heparin-bonded central venous catheters do not reduce thrombosis in infants with congenital heart disease: a blinded randomized, controlled trial. Pediatrics 2009; 123: e453-458.
49. Akl EA, et al. Thromboprophylaxis for patients with cancer and central venous catheters: a systematic review and a meta-analysis. Cancer 2008; 112: 2483-2492.
50. Streiff MB. The National Comprehensive Cancer Center Network (NCCN) guidelines on the management of venous thromboembolism in cancer patients. Thromb Res 2010; 125 (Suppl 2): S128-133.
51. Urschel HC, Jr., Razzuk MA. Paget-Schroetter syndrome: what is the best management? Ann Thorac Surg 2000; 69: 1663-1669.
52. Sanders RJ, et al. Diagnosis of thoracic outlet syndrome. J Vasc Surg 2007; 46: 601-604.
53. Constans J, et al. A clinical prediction score for upper extremity deep venous thrombosis. Thromb Haemost 2008; 99: 202-207.
54. Knudson GJ, et al. Color Doppler sonographic imaging in the assessment of upper-extremity deep venous thrombosis. Am J Roentgenol 1990; 154: 399-403.
55. Merminod T, et al. Limited usefulness of D-dimer in suspected deep vein thrombosis of the upper extremities. Blood Coagul Fibrinolysis 2006; 17: 225-226.
56. Baarslag HJ, et al. Prospective study of color duplex ultrasonography compared with contrast venography in patients suspected of having deep venous thrombosis of the upper extremities. Ann Intern Med 2002; 136: 865-872.
57. Patel MC, et al. Subclavian and internal jugular veins at Doppler US: abnormal cardiac pulsatility and respiratory phasicity as a predictor of complete central occlusion. Radiology 1999; 211: 579-583.
58. Di Nisio M, et al. Accuracy of diagnostic tests for clinically suspected upper extremity deep vein thrombosis: a systematic review. J Thromb Haemost 2010; 8: 684-692.
59. Bates SM, et al. Diagnosis of DVT: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e351S-e418S.
60. Hull R, et al. Clinical validity of a negative venogram in patients with clinically suspected venous thrombosis. Circulation 1981; 64: 622-625.
61. Rabinov K, Paulin S. Roentgen diagnosis of venous thrombosis in the leg. Arch Surg 1972; 104: 134-144.
62. Baarslag HJ, et al. Deep vein thrombosis of the upper extremity: intra- and inter-observer study of digital subtraction venography. Eur Radiol 2003; 13: 251-255.
63. Leizorovicz A, et al. The assessment of deep vein thromboses for therapeutic trials. Angiology 2003; 54: 19-24.
64. Heye S, et al. Upper-extremity venography: CO2 versus iodinated contrast material. Radiology 2006; 241: 291-297.
65. Thomas SM, et al. Diagnostic value of CT for deep vein thrombosis: results of a systematic review and meta-analysis. Clin Radiol 2008; 63: 299-304.
66. Kim H, et al. Role of CT venography in the diagnosis and treatment of benign thoracic central venous obstruction. Korean J Radiol 2003; 4: 146-152.
67. Sampson FC, et al. The accuracy of MRI in diagnosis of suspected deep vein thrombosis: systematic review and meta-analysis. Eur Radiol 2007; 17: 175-181.
68. Stein PD, et al. Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med 2010; 152: 434-443, W142-3.
69. Oxtoby JW, et al. 3D gadolinium-enhanced MRI venography: evaluation of central chest veins and impact on patient management. Clin Radiol 2001; 56: 887-894.
70. Tanju S, et al. Direct contrast-enhanced 3D MR venography evaluation of upper extremity deep venous system. Diagn Interv Radiol 2006; 12: 74-79.
71. Thornton MJ, et al. A three-dimensional gadolinium-enhanced MR venography technique for imaging central veins. AJR Am J Roentgenol 1999; 173: 999-1003.
72. Baarslag HJ, et al. Magnetic resonance venography in consecutive patients with suspected deep vein thrombosis of the upper extremity: initial experience. Acta Radiol 2004; 45: 38-43.
73. Baarslag HJ, et al. Diagnosis and management of deep vein thrombosis of the upper extremity: a review. Eur Radiol 2004; 14: 1263-1274.
74. Rose SC, et al. MR angiography for mapping potential central venous access sites in patients with advanced venous occlusive disease. Am J Roentgenol 1996; 166: 1181-1187.
75. Hartnell GG, et al. Magnetic resonance angiography of the central chest veins. A new gold standard? Chest 1995; 107: 1053-1057.
76. Fraser DG, et al. Diagnosis of lower-limb deep venous thrombosis: a prospective blinded study of magnetic resonance direct thrombus imaging. Ann Intern Med 2002; 136: 89-98.
77. Kearon C. A conceptual framework for two phases of anticoagulant treatment of venous thromboembolism. J Thromb Haemost 2012; 10: 507-511.
78. Sajid MS, et al. Upper limb deep vein thrombosis: a literature review to streamline the protocol for management. Acta Haematol 2007; 118: 10-18.
79. Laerum F, Holm HA. Postphlebographic thrombosis: a double-blind study with methylglucamine metrizoate and metrizamide. Radiology 1981; 140: 651-654.
80. Heijboer H, et al. Clinical utility of real-time compression ultrasonography for diagnostic management of patients with recurrent venous thrombosis. Acta Radi-ologica 1992; 33: 297-300.
81. Cronan JJ, Leen V. Recurrent deep venous thrombosis: limitations of US. Radiology 1989; 170: 739-742.
82. Linkins LA, et al. Interobserver agreement on ultrasound measurements of residual vein diameter, thrombus echogenicity and Doppler venous flow in patients with previous venous thrombosis. Thromb Res 2006; 117: 241-247.
83. Baglin T, et al. Duration of anticoagulant therapy after a first episode of unprovoked pulmonary embolus or deep vein thrombosis: guidance from the scientific and standardization committee of the international society on thrombosis and haemostasis. J Thromb Haemost 2012; 10: 698-702.
84. Goldhaber SZ, et al. Pooled analyses of randomized trials of streptokinase and he-parin in phlebographically documented acute deep venous thrombosis. Am J Med 1984; 76: 393-397.
85. Vedantham S. Interventions for Deep Vein Thrombosis: Reemergence of a Promising Therapy. Am J Med 2008; 121: S28-S39.
86. Vedantham S, et al. Society of Interventional Radiology position statement: treatment of acute iliofemoral deep vein thrombosis with use of adjunctive catheter-directed intrathrombus thrombolysis. J Vasc Interv Radiol 2006; 17: 613-616.
87. Murphy EH, et al. Endovascular intervention for lower extremity deep venous thrombosis. In: Peripheral Endovascular Interventions. 3rd ed. Springer, New York; 2010; pp. 203-213.
88. Sharafuddin MJ, et al. Endovascular management of venous thrombotic diseases of the upper torso and extremities. J Vasc Interv Radiol 2002; 13: 975-990.
89. Maleux G, et al. Catheter-directed thrombolytic therapy for thoracic deep vein thrombosis is safe and effective in selected patients with and without cancer. Eur Radiol 2010; 20: 2293-2300.
90. Enden T, et al. Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency. J Thromb Haemost 2009; 7: 1268-1275.
91. Wicky ST. Acute deep vein thrombosis and thrombolysis. Tech Vasc Interv Radiol 2009; 12: 148-153.
92. Comerota AJ. Randomized trial evidence supporting a strategy of thrombus removal for acute DVT. Semin Vasc Surg 2010; 23: 192-198.
93. Sheynzon V, et al. Power pulse spray pharmacomechanical thrombectomy for the treatment of upper extremity deep vein thrombosis. J Vasc Interv Radiol 2008; Supplement: S132.
94. Urschel HC, Jr., Patel AN. Paget-Schroetter syndrome therapy: failure of intravenous stents. Ann Thorac Surg 2003; 75: 1693-1696.
95. Oderich GS, et al. Stent placement for treatment of central and peripheral venous obstruction: a long-term multi-institutional experience. J Vasc Surg 2000; 32: 760-769.
96. Schneider DB, et al. Combination treatment of venous thoracic outlet syndrome: open surgical decompression and intraoperative angioplasty. J Vasc Surg 2004; 40: 599-603.
97. Sadaf A, et al. Significant caval penetration by the celect inferior vena cava filter: attributable to filter design? J Vasc Interv Radiol 2007; 18: 1447-1450.
98. Adams JT, DeWeese JA. "Effort" thrombosis of the axillary and subclavian veins. J Trauma 1971; 11: 923-930.
99. Kovacs MJ, et al. A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost 2007; 5: 1650-1653.